Contemporary Use and Effectiveness of N-Acetylcysteine in Preventing Contrast-Induced Nephropathy Among Patients Undergoing Percutaneous Coronary Intervention
Authors:
- Hitinder S. GurmHGHitinder S. Gurm
- Dean E. SmithDSDean E. Smith
- Otavio BerwangerOBOtavio Berwanger
- David ShareDSDavid Share
- Theodore SchreiberTSTheodore Schreiber
- Mauro MoscucciMMMauro Moscucci
- Brahmajee K. NallamothuBNBrahmajee K. Nallamothu
- 1 January 2012
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 5 (1) , 98-104
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced NephropathyAnnals of Internal Medicine, 2008
- Renal failure in 57925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast mediaKidney International, 2006
- Prophylaxis Strategies for Contrast-Induced NephropathyJAMA, 2006
- Preventing Nephropathy Induced by Contrast MediumNew England Journal of Medicine, 2006
- Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysisThe American Journal of Medicine, 2004
- Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast doseThe American Journal of Cardiology, 2002
- Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary InterventionCirculation, 2002
- Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by AcetylcysteineNew England Journal of Medicine, 2000
- Effects of Saline, Mannitol, and Furosemide on Acute Decreases in Renal Function Induced by Radiocontrast AgentsNew England Journal of Medicine, 1994
- High-dose contrast agent administration during complex coronary angioplastyAmerican Heart Journal, 1990